Cargando…

A New Therapy for Uncomplicated Vulvovaginal Candidiasis and Its Impact on Vaginal Flora

Background: An estimated 75% of women will have one episode of vulvovaginal candidiasis (VCC) during their lifetime, and 40–50% of these will experience further episodes. The high incidence of vulvovaginal candidiasis, combined with the problems of azole resistance and toxicity, highlights the neces...

Descripción completa

Detalles Bibliográficos
Autores principales: Stabile, Guglielmo, Gentile, Roberta Marie, Carlucci, Stefania, Restaino, Stefano, De Seta, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625853/
https://www.ncbi.nlm.nih.gov/pubmed/34828601
http://dx.doi.org/10.3390/healthcare9111555
_version_ 1784606523283996672
author Stabile, Guglielmo
Gentile, Roberta Marie
Carlucci, Stefania
Restaino, Stefano
De Seta, Francesco
author_facet Stabile, Guglielmo
Gentile, Roberta Marie
Carlucci, Stefania
Restaino, Stefano
De Seta, Francesco
author_sort Stabile, Guglielmo
collection PubMed
description Background: An estimated 75% of women will have one episode of vulvovaginal candidiasis (VCC) during their lifetime, and 40–50% of these will experience further episodes. The high incidence of vulvovaginal candidiasis, combined with the problems of azole resistance and toxicity, highlights the necessity for new strategies for the treatment of this condition. In this context, natural compounds represent promising alternatives. Methods: We enrolled, between January 2020 and April 2021, forty women affected by uncomplicated vulvovaginal candidiasis. Women were divided into two groups. In the first group, we treated 20 women with clotrimazole daily administration for six days. In the second group, 20 women were treated with clotrimazole associated with Unilen(®) Microbio+, a new product containing Saccharomyces cerevisiae, melatonin, and GLA-14. Women underwent a check at days 15, 30, and 90. A clinical and cultural examination were performed to establish the effect of the treatments on vaginal flora. Results: In the group treated with Unilen(®) Microbio+, clinical and microbiological cure at 15 and 30 days was observed in 18 women (90%), compared with 16 women (80%) in the group treated only with clotrimazole. The efficacy of the association between clotrimazole and Unilen(®) Microbio+ in these uncomplicated forms was therefore not inferior to the azole treatment alone. Only four women (20%) in the Unilen(®) Microbio+ group presented symptomatic recurrences within the 3 months, compared with eight women (40%) in the clotrimazole-only group. Microscopic wet mount analysis at 1 and 3 months demonstrated a significant increase in lactobacillus count and a reduction in the polymorphonucleate cells in the Unilen(®) Microbio+ group. Conclusions: Unilen(®) Microbio+ supplementation was demonstrated to cure uncomplicated vulvovaginal candidiasis with clotrimazole, reducing recurrence and improving vaginal flora better than clotrimazole treatment alone.
format Online
Article
Text
id pubmed-8625853
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86258532021-11-27 A New Therapy for Uncomplicated Vulvovaginal Candidiasis and Its Impact on Vaginal Flora Stabile, Guglielmo Gentile, Roberta Marie Carlucci, Stefania Restaino, Stefano De Seta, Francesco Healthcare (Basel) Communication Background: An estimated 75% of women will have one episode of vulvovaginal candidiasis (VCC) during their lifetime, and 40–50% of these will experience further episodes. The high incidence of vulvovaginal candidiasis, combined with the problems of azole resistance and toxicity, highlights the necessity for new strategies for the treatment of this condition. In this context, natural compounds represent promising alternatives. Methods: We enrolled, between January 2020 and April 2021, forty women affected by uncomplicated vulvovaginal candidiasis. Women were divided into two groups. In the first group, we treated 20 women with clotrimazole daily administration for six days. In the second group, 20 women were treated with clotrimazole associated with Unilen(®) Microbio+, a new product containing Saccharomyces cerevisiae, melatonin, and GLA-14. Women underwent a check at days 15, 30, and 90. A clinical and cultural examination were performed to establish the effect of the treatments on vaginal flora. Results: In the group treated with Unilen(®) Microbio+, clinical and microbiological cure at 15 and 30 days was observed in 18 women (90%), compared with 16 women (80%) in the group treated only with clotrimazole. The efficacy of the association between clotrimazole and Unilen(®) Microbio+ in these uncomplicated forms was therefore not inferior to the azole treatment alone. Only four women (20%) in the Unilen(®) Microbio+ group presented symptomatic recurrences within the 3 months, compared with eight women (40%) in the clotrimazole-only group. Microscopic wet mount analysis at 1 and 3 months demonstrated a significant increase in lactobacillus count and a reduction in the polymorphonucleate cells in the Unilen(®) Microbio+ group. Conclusions: Unilen(®) Microbio+ supplementation was demonstrated to cure uncomplicated vulvovaginal candidiasis with clotrimazole, reducing recurrence and improving vaginal flora better than clotrimazole treatment alone. MDPI 2021-11-16 /pmc/articles/PMC8625853/ /pubmed/34828601 http://dx.doi.org/10.3390/healthcare9111555 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Stabile, Guglielmo
Gentile, Roberta Marie
Carlucci, Stefania
Restaino, Stefano
De Seta, Francesco
A New Therapy for Uncomplicated Vulvovaginal Candidiasis and Its Impact on Vaginal Flora
title A New Therapy for Uncomplicated Vulvovaginal Candidiasis and Its Impact on Vaginal Flora
title_full A New Therapy for Uncomplicated Vulvovaginal Candidiasis and Its Impact on Vaginal Flora
title_fullStr A New Therapy for Uncomplicated Vulvovaginal Candidiasis and Its Impact on Vaginal Flora
title_full_unstemmed A New Therapy for Uncomplicated Vulvovaginal Candidiasis and Its Impact on Vaginal Flora
title_short A New Therapy for Uncomplicated Vulvovaginal Candidiasis and Its Impact on Vaginal Flora
title_sort new therapy for uncomplicated vulvovaginal candidiasis and its impact on vaginal flora
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625853/
https://www.ncbi.nlm.nih.gov/pubmed/34828601
http://dx.doi.org/10.3390/healthcare9111555
work_keys_str_mv AT stabileguglielmo anewtherapyforuncomplicatedvulvovaginalcandidiasisanditsimpactonvaginalflora
AT gentilerobertamarie anewtherapyforuncomplicatedvulvovaginalcandidiasisanditsimpactonvaginalflora
AT carluccistefania anewtherapyforuncomplicatedvulvovaginalcandidiasisanditsimpactonvaginalflora
AT restainostefano anewtherapyforuncomplicatedvulvovaginalcandidiasisanditsimpactonvaginalflora
AT desetafrancesco anewtherapyforuncomplicatedvulvovaginalcandidiasisanditsimpactonvaginalflora
AT stabileguglielmo newtherapyforuncomplicatedvulvovaginalcandidiasisanditsimpactonvaginalflora
AT gentilerobertamarie newtherapyforuncomplicatedvulvovaginalcandidiasisanditsimpactonvaginalflora
AT carluccistefania newtherapyforuncomplicatedvulvovaginalcandidiasisanditsimpactonvaginalflora
AT restainostefano newtherapyforuncomplicatedvulvovaginalcandidiasisanditsimpactonvaginalflora
AT desetafrancesco newtherapyforuncomplicatedvulvovaginalcandidiasisanditsimpactonvaginalflora